So we are all familiar with Hashan’s paper written about Neuren in Feb 2022 - A de-risked biotech with 4x upside when he was working for karst peak capital.https://www.livewiremarkets.com/wires/a-de-risked-biotech-with-4x-upside#
Well, he has backed it up, and has now written an updated paper as the founder of KP Rx. You can read it here
https://www.livewiremarkets.com/wires/neuren-where-to-from-here-2024-03-23
So we are all familiar with Hashan’s paper written about Neuren...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.92 |
Change
-0.180(1.37%) |
Mkt cap ! $1.607B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.90 | $2.558M | 194.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 327 | $12.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.93 | 323 | 15 |
View Market Depth
| Last trade - 13.09pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |